Scientists uncover drivers of recurrent arthritis after immunotherapy, suggesting potential biomarkers

Дата публикации: 12-08-2026 16:20:07

A new study led by researchers at The University of Texas MD Anderson Cancer Center has shown that inflammatory arthritis occurring as a side effect of immune checkpoint inhibitors behaves like an immune-memory disease, suggesting that certain immune cell populations could serve as biomarkers or targets for therapies.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New mechanism may help predict and improve macrophage-targeted cancer immunotherapy	0	7.03	14-08-2026
2	This drug delayed rheumatoid arthritis for years after treatment ended	0	6.65	01-06-2026
3	Researchers develop mathematical measures to better personalize therapy for prostate cancer	0	7.4	13-08-2026
4	CAR-T терапия опухолей вызывает легкую когнитивную дисфункцию	0	0	12-05-2025
5	Immuntherapien gegen Krebs: Warum der Erfolg oft begrenzt ist	0	8.04	15-08-2026
6	Scientists uncover 'hidden switch' that helps cancer cells hide from the immune system	0	4.74	13-08-2026
7	Studie aus Essen: Sport stärkt das Immunsystem auch bei fortgeschrittenem Krebs	0	8.26	30-06-2026
8	Talquetamab Plus Daratumumab and Pomalidomide and Talquetamab Plus Daratumumab Prolong PFS Among Previously Treated Patients with Relapsed Or Refractory Multiple Myeloma	0	5	02-07-2026
9	If you have arthritis, these activities may lower hip-replacement risk	0	13.7	19-07-2026
10	Novel biomarker research offers new hope in the fight against colorectal cancer	7	8	06-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.62. Источник: medicalxpress.com.